CVE-2018-13379
Published: November 3, 2021
Official Description
Fortinet FortiOS SSL VPN web portal contains a path traversal vulnerability that may allow an unauthenticated attacker to download FortiOS system files through specially crafted HTTP resource requests.
CISA KEV Advisory
Fortinet FortiOS SSL VPN Path Traversal Vulnerability
Fortinet FortiOS SSL VPN web portal contains a path traversal vulnerability that may allow an unauthenticated attacker to download FortiOS system files through specially crafted HTTP resource requests.
Apply updates per vendor instructions.
Risk Analysis
Fortinet FortiOS SSL VPN web portal contains a path traversal vulnerability, allowing unauthenticated attackers to download system files. The high EPSS score of 0.94475 indicates a significant likelihood of exploitation, making this a serious concern.
This vulnerability is actively exploited in the wild and is listed in CISA's KEV catalog, confirming its active use by threat actors. It is remotely exploitable without authentication.
Administrators should apply the latest security patches or upgrades for Fortinet FortiOS to address this path traversal vulnerability and prevent unauthorized file access.
Technical Analysis
CVE-2018-13379 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2018-13379 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Affected Vendors & Products
Exploit & PoC Resources
All References (1)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2018-13379 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1